跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 9,876 条关于
“ATyr Pharma”
全部
9,876
临床试验
4,247
药物
1,162
机构
1,220
资讯
3,247
去年
aTyr Pharma Advances Novel Anti-Fibrotic Therapy ATYR0101 for Pulmonary Fibrosis
去年
ATyr Pharma's Efzofitimod Fails Phase 3 Trial for Pulmonary Sarcoidosis
去年
aTyr Pharma's Efzofitimod Shows Promise in Pulmonary Sarcoidosis and SSc-ILD Trials
去年
aTyr Pharma Completes Phase 3 Enrollment for Pulmonary Sarcoidosis Treatment, Results Expected Q3 2025
去年
aTyr Pharma's Efzofitimod Shows Continued Promise in Phase 3 Pulmonary Sarcoidosis Trial
去年
Novel Pipeline Therapies Show Promise for Pulmonary Sarcoidosis Treatment
去年
SSc-ILD Market Projected to Reach $750 Million by 2034 as Novel Therapies Enter Pipeline
去年
Science Translational Medicine Validates Efzofitimod's Novel Mechanism for Treating Lung Inflammation
去年
Q3 2025 Biopharma Catalyst Monitor Highlights 18 Key FDA Decisions and Clinical Trial Milestones
3个月前
Vir Biotechnology Appoints Timothy Coughlin to Board of Directors Amid Pipeline Advancement
第 1 页,共 325 页
上一页
下一页